Molecular docking of different inhibitors and activators to butyrylcholinesterase

References

• Bartolucci, C., Perola, E., Cellai, L., Brufani, M., & Lamba, D. (1999). Back door opening implied by the crystal structure of a carbamoylated acetylcholinesterase. Biochemistry, 38, 5714–5719.10.1021/bi982723p
   PubMed Web of Science ®Google Scholar
• Carolan, C. G., Dillon, G. P., Khan, D., Ryder, S. A., Gaynor, J. M., Reidy, S., … Gilmer, J. F. (2009). Isosorbide-2-benzyl carbamate-5-salicylate, a peripheral anionic site binding subnanomolar selective butyrylcholinesterase inhibitor. Journal of Medicinal Chemistry, 53, 1190–1199.
   Web of Science ®Google Scholar
• Cavalier, J.-F., Buono, G., & Verger, R. (2000). Covalent inhibition of digestive lipases by chiral phosphonates. Accounts of Chemical Research, 33, 579–589.10.1021/ar990150i
   PubMed Web of Science ®Google Scholar
• Chiou, S.-Y., Wu, Y.-G., & Lin, G. (2008). Activation mechanisms of butyrylcholinesterase by 2,4,6-trinitrotoluene, 3,3-dimethylbutyl-N-n-butylcarbamate, and 2-trimethylsilyl-ethyl-N-n-butylcarbamate. Applied Biochemistry and Biotechnology, 150, 337–344.10.1007/s12010-008-8295-z
   PubMed Web of Science ®Google Scholar
• Chiou, S.-Y., Wu, Y.-G., Lin, Y.-F., Lin, L.-Y., & Lin, G. (2007). Substrate activation of butyrylcholinesterase and substrate inhibition of acetylcholinesterase by 3,3-dimethylbutyl-N-n-butylcarbamate and 2-trimethylsilyl-ethyl-N-n-butylcarbamate. Journal of Biochemical and Molecular Toxicology, 21, 24–31.10.1002/(ISSN)1099-0461
   PubMed Web of Science ®Google Scholar
• Darvesh, S., Darvesh, K. V., McDonald, R. S., Mataija, D., Walsh, R., Mothana, S., … Martin, E. (2008). Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase. Journal of Medicinal Chemistry, 51, 4200–4212.10.1021/jm8002075
   PubMed Web of Science ®Google Scholar
• Darvesh, S., Hopkins, D. A., & Geula, C. (2003). Neurobiology of butyrylcholinesterase. Nature Revews, 4, 131–138.
   PubMed Web of Science ®Google Scholar
• Decker, M. (2006). Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase. Journal of Medicinal Chemistry, 49, 5411–5413.10.1021/jm060682m
   PubMed Web of Science ®Google Scholar
• Dvir, H., Silman, I., Harel, M., Rosenberry, T. L., & Sussman, J. L. (2010). Acetylcholinesterase: From 3D structure to function. Chemico-Biological Interactions, 187, 10–22.10.1016/j.cbi.2010.01.042
   PubMed Web of Science ®Google Scholar
• Ellman, G. L., Courtney, K. D., Andres, V. J., & Featherstone, R. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology, 7, 88–95.10.1016/0006-2952(61)90145-9
   PubMed Web of Science ®Google Scholar
• Elsinghorst, P. W., Cieslik, J. S., Mohr, K., Trankle, C., & Gutschow, M. (2007). First gallamine-tacrine hybrid: Design and characterization at cholinesterase and the M2 muscarinic receptor. Journal of Medicinal Chemistry, 50, 5685–5695.10.1021/jm070859s
   PubMed Web of Science ®Google Scholar
• Eskander, M. F., Nagykery, N. G., Leung, E. Y., Khelghati, B., & Geula, C. (2005). Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer’s plaques and tangles. Brain Research, 1060, 144–152.10.1016/j.brainres.2005.08.039
   PubMed Web of Science ®Google Scholar
• Goodsell, D. S., Lauble, H., Stout, C. D., & Olson, A. J. (1993). Automated docking in crystallography: Analysis of the substrates of aconitase. Proteins: Structure, Function, and Genetics, 17, 1–10.10.1002/(ISSN)1097-0134
   PubMed Web of Science ®Google Scholar
• Goodsell, D. S., Morris, G. M., & Olson, A. J. (1996). Automated docking of flexible ligands: Applications of autodock. Journal of Molecular Recognition, 9, 1–5.10.1002/(ISSN)1099-1352
   PubMed Web of Science ®Google Scholar
• Goodsell, D. S., & Olson, A. J. (1990). Automated docking of substrates to proteins by simulated annealing. Proteins: Structure, Function, and Genetics, 8, 195–202.10.1002/(ISSN)1097-0134
   PubMed Web of Science ®Google Scholar
• Greig, N. H., Utsuki, T., Ingram, D. K., Wang, Y., Pepeu, G., Scali, C., … Lahiri, D. K. (2005). Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent. Proceedings of the National Academy of Sciences, 102, 17213–17218.10.1073/pnas.0508575102
   PubMed Web of Science ®Google Scholar
• Hosie, L., Sutton, L. D., & Quinn, D. M. (1987). p-Nitrophenyl and cholesteryl-N-alkyl carbamates as inhibitors of cholesterol esterase. Journal Biological Chemistry, 262, 260–264.
   PubMed Web of Science ®Google Scholar
• Li, B., Stribley, J. A., Ticu, A., Xie, W., Schoper, L. M., Hammond, P., Brimijoin, S., Hinrichs, S. H., & Lockridge, O. (2000). Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. Journal of Neurochemistry, 75, 1320–1331.
   PubMed Web of Science ®Google Scholar
• Lin, G., & Lai, C.-Y. (1995). Hammett analysis of the inhibition of pancreatic cholesterol esterase by substituted phenyl-N-butylcarbamate. Tetrahedron Letters, 36, 6117–6120.10.1016/0040-4039(95)01233-8
   Web of Science ®Google Scholar
• Lin, M.-C., Lin, G.-Z., Hwang, C.-I., Jian, S.-Y., Lin, J., Shen, Y.-F., & Lin, G. (2012). Synthesis and evaluation of a new series of tri-, di-, and mono-N-alkylcarbamylphloroglucinols as conformationally constrained inhibitors of cholesterol esterase. Protein Science, 21, 1344–1357.10.1002/pro.2121
   PubMed Web of Science ®Google Scholar
• Lin, M.-C., Lin, G.-Z., Shen, Y.-F., Jian, S.-Y., Hsieh, D.-K., Lin, J., & Lin, G. (2012). Synthesis and evaluation of a new series of tri-, di-, and mono-N-alkylcarbamyl- phloroglucinols as bulky inhibitors of acetylcholinesterase. Chemical Research in Toxicology, 25, 1462–1471.10.1021/tx300119a
   PubMed Web of Science ®Google Scholar
• Lin, G., Shieh, C.-T., Ho, H.-C., Chouhwang, J.-Y., Lin, W.-Y., & Lu, C.-P. (1999). Structure–reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase. Biochemistry, 38, 9971–9981.10.1021/bi982775e
   PubMed Web of Science ®Google Scholar
• Lin, G., Tsai, H.-J., & Tsai, Y.-H. (2003). Cage amines as the stopper inhibitors of cholinesterases. Bioorganic & Medicinal Chemistry Letters, 13, 2887–2890.10.1016/S0960-894X(03)00599-7
   PubMed Web of Science ®Google Scholar
• Lin, G., Tseng, H.-C., Chio, A.-C., Tseng, T.-M., & Tsai, B.-Y. (2005). A rate determining step change in the pre-steady state of acetylcholinesterase inhibitions by 1,n-alkane-di-N-butycarbamates. Bioorganic & Medicinal Chemistry Letters, 15, 951–955.10.1016/j.bmcl.2004.12.058
   PubMed Web of Science ®Google Scholar
• Loudwig, S., Nicolet, Y., Masson, P., Fontecilla-Camps, J. C., Bon, S., Nachon, F., & Goeldner, M. (2003). Photoreversible inhibition of cholinesterases: Catalytic serine-labeled caged butyrylcholinesterase. ChemBioChem, 4, 762–767.10.1002/cbic.200300571
   PubMed Web of Science ®Google Scholar
• Luo, W., Yu, Q.-S., Kulkarni, S. S., Parrish, D. A., Holloway, H. W., Tweedie, D., Shafferman, A., … Greig, N. H. (2006). Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (−)- and (+)-tetrahydro- furobenzofuran and methanobenzodioxepine. Journal of Medicinal Chemistry, 49, 2174–2185.10.1021/jm050578p
   PubMed Web of Science ®Google Scholar
• Masson, P., Froment, M.-T., Fort, S., Ribes, F., Bec, N., Balny, C., & Schopfer, L. M. (2002). Butyrylcholinesterase-catalyzed hydrolysis of N-methylindoxyl acetate: Analysis of volume changes upon reaction and hysteretic behavior. Biochimica et Biophysica Acta (BBA) – Protein Structure and Molecular Enzymology, 1597, 229–243.10.1016/S0167-4838(02)00265-0
   PubMed Web of Science ®Google Scholar
• Mesulam, M. M., Mufson, E. J, Wainer, B. H., & Levey, A. I. (2002). Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience, 110, 627–639.10.1016/S0306-4522(01)00613-3
   PubMed Web of Science ®Google Scholar
• Nicolet, Y., Lockridge, O., Masson, P., Fontecilla-Camps, J. C., & Nachon, F. (2003). Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. Journal of Biological Chemistry, 278, 41141–41147.10.1074/jbc.M210241200
   PubMed Web of Science ®Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera-a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25, 1605–1612.10.1002/(ISSN)1096-987X
   PubMed Web of Science ®Google Scholar
• Pietsch, M., & Gütschow, M. (2002). Alternate substrate inhibition of cholesterol esterase by thieno[2,3-d][1,3]oxazin-4-ones. Journal of Biological Chemistry, 277, 24006–24013.10.1074/jbc.M112252200
   PubMed Web of Science ®Google Scholar
• Pietsch, M., & Gütschow, M. (2005). Syntehsis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition. Journal of Medicinal Chemistry, 48, 8270–8288.10.1021/jm0508639
   PubMed Web of Science ®Google Scholar
• Reid, G. A., Chilukure, N., & Darvesh, S. (2013). Butyrylcholinesterase and the cholinergic system. Neuroscience, 234, 53–68.10.1016/j.neuroscience.2012.12.054
   PubMed Web of Science ®Google Scholar
• Savini, L., Gaeta, A., Fattorusso, C., Catalanotti, B., Campiani, G., Chiasserini, L., … Saxena, A. (2003). Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors. Journal of Medicinal Chemistry, 46, 1–4.10.1021/jm0255668
   PubMed Web of Science ®Google Scholar
• Sussman, J. L., Harel, M., Frolow, F., Oefner, C., Goldman, A., Toker, L., & Silman, I. (1991). Atomic structure of acetylcholinesterase from Torpedo californica: A prototypic acetylcholine-binding protein. Science, 253, 872–879.10.1126/science.1678899
   PubMed Web of Science ®Google Scholar
• Taylor, P., & Raduc, Z. (1994). The cholinesterases: From genes to proteins. Annual Review of Pharmacology and Toxicology, 34, 281–320.10.1146/annurev.pa.34.040194.001433
   PubMed Web of Science ®Google Scholar
• Tormos, R. J., Wiley, K. L., Seravali, J., Nachon, F., Masson, P., Nicolet, Y., & Quinn, D. M. (2005). The reactant state for substrate-activated turnover of acetylthiocholine by butyrylcholinesterase is a tetrahedral intermediate. Journal of the American Chemical Society, 127, 14538–14539.10.1021/ja052401q
   PubMed Web of Science ®Google Scholar
• Zhan, C.-G., Zheng, F., & Landry, D. W. (2003). Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase. Journal of the American Chemical Society, 125, 2462–2474.10.1021/ja020850+
   PubMed Web of Science ®Google Scholar